Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium

Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium

Saved in:
Bibliographic Details
Published in:Cytotherapy (Oxford, England) Vol. 23; no. 5; pp. S27 - S29
Main Authors: Curran, K.J., Fabrizio, V.A., Mauguen, A., Boelens, J.J., Baggott, C., Prabhu, S., Placenta, H., Phillips, C.L., Rossoff, J., Stefanski, H., Talano, J., Moskop, A., Margossian, S.P., Verneris, M.R., Myers, G., Karras, N.A., Brown, P.A., Qayed, M., Hermiston, M., Satwani, P., Krupski, C., Keating, A., Wilcox, R., Rabik, C.A., Chinnabhandar, V., Kunicki, M., Goksenin, A., Mackall, C., Laetsch, T.W., Schultz, L.M.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-05-2021
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1465-3249
1477-2566
DOI:10.1016/S1465324921002899